Sushmita Panda on Muck Rack

Sushmita Panda

Verified
(She/Her)
Delhi
As seen in: Citeline, Scrip, MSN Canada, MSN India, Sputnik, Financial Express, INDIA TV, EIN News, Space Daily, The Sunday Guardian, The Daily Guardian, Yerepouni Daily News
Covers:  Pharma, Healthcare, Drug Discovery, Drug Access, Mental Health, Women's Health, Health Policy and more
Doesn't Cover: Entertainment, Lifestyle, and sports.
Global Pharma Reporter @PharmaScrip, @Citeline | Alum: @acjindia | tip/lead: sushmita.panda@norstella.com

Get in touch with Sushmita

Contact Sushmita, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Sushmita Panda’s Biography

Read Full Bio →

Sushmita Panda is a New Delhi-based journalist with over six years of experience covering the healthcare and pharmaceutical sectors. She has reported on critical issues including drug patents and discovery, rare diseases, innovative therapies, women’s health, Neglected Tropical Diseases (NTDs), mental health, drug access, and regulatory affairs. Over the years, she has authored numerous in-depth stories and on-ground reports on diseases prevalent in India, including several exclusives and inter…

Sushmita Panda’s Journalist Portfolio

Fatal Thirst

Fatal Thirst

Fluorosis is a chronic condition caused by excessive intake of fluorine compounds, marked by mottling of the …

View article →
Digging up the Piles

Digging up the Piles

Our inefficiency as a society to come up with a proper mechanism of disposal has led to manifold consequences…

View article →
Pharma Set to Lose Millions as India Mulls Dropping Remdesivir To Treat COVID-19

Pharma Set to Lose Millions as India Mulls Dropping Remdesivir To Treat COVID-19

Just as India's drug manufacturers and pharma businesses are catching up with demands for anti-viral drug Rem…

View article →
'Lung diseases rise, but pulmonary function tests ignored' - The Sunday Guardian Live

'Lung diseases rise, but pulmonary function tests ignored' - The Sunday Guardian Live

New Delhi: Despite Chronic Obstructive Pulmonary Disease (COPD) cases rising, Pulmonary Function Tests (PFTs)…

View article →
Uncontrolled Diabetes, Steroids Misuse Causing Black Fungus Menace in India

Uncontrolled Diabetes, Steroids Misuse Causing Black Fungus Menace in India

The menace of black fungus, or mucormycosis, has hindered India's fight against the coronavirus pandemic. Acc…

View article →

Articles

RQ Bio Raises $115m Series A To Advance Long-Acting Influenza Antibody RQB01

|
By Sushmita Panda Verified
| Scrip Verified
The financing provides fresh capital for the firm's next stage of growth, including the progression of RQB01 toward clinical development. RQ Bio has raised $115m through an oversubscribed Series A financing round to support clinical development of its lead long-acting antibody candidate, RQB01, which is being developed as a single-administration therapy designed to provide season-long influenza protection in high-risk and immunocompromised populations.
Open in Who Shared Issue with article?

Definium Proposes $500m Offering Following Phase III MDD Win For DT120

|
By Sushmita Panda Verified
| Scrip Verified
The proposed offering could help advance Definium's pipeline and support a potential launch for DT120. Definium Therapeutics (formerly Mind Medicine) disclosed plans to raise $500m through a public offering on the back of positive Phase III results for its LSD-derived oral therapy, DT120, in patients with major depressive disorder (MDD). The public offering, which could support advancing its pipeline and preparing for the potential commercialization of its lead candidate DT120,...
Open in Who Shared Issue with article?

Denali Monetizes Rare Pediatric Disease Voucher In $195m Deal After Avlayah FDA Nod

|
By Sushmita Panda Verified
| Scrip Verified
The voucher sale gives Denali additional financial flexibility as it seeks to advance therapies spanning lysosomal storage disorders and neurodegenerative diseases.
Open in Who Shared Issue with article?
See all 1,363 licensed articles (1,368 Total)

Interview

See all →

Have you ever used a typewriter?

Never.

How is social media changing news?

Social media helps in promoting stories which helps more people to get access to it, but it also spread fake news.

How do you prefer to be pitched on stories?

In a creative and interesting manner.
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified